Skip to main content

REGENXBIO Inc.

RGNX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001590877

In the last 90 days, REGENXBIO Inc. insiders filed 1 open-market purchase and 0 sales; 165 institutions reported holding it in 13F filings for Q2 2026, worth $504.6M in total; no superinvestor holds it.

Q2 2025 vs. Q1 2025

How the institutions holding REGENXBIO Inc. changed between Q1 2025 and Q2 2025.

All holders in Q2 2025All holders in Q1 2025

13F holders of RGNX: Q1 2025 compared with Q2 2025
MeasureQ1 2025Of which not filed for Q2 2025Q2 2025Change
Holders1642159−3
Shares41.7M31.8K42.0M+374.7K (+0.9%)
Value$298.0M$227.6K$344.9M+$47.2M (+15.9%)

2 institutions that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (25)

Institutions that held REGENXBIO Inc. at the end of Q2 2025 but not at the end of Q1 2025.

Institutions new to RGNX in Q2 2025
InstitutionSharesValue% of portfolio
Y-Intercept (Hong Kong) Ltd176,999$1.45M0.04%
Nebula Research & Development LLC151,293$1.24M0.11%
Los Angeles Capital Management LLC125,408$1.03M0.00%
Rafferty Asset Management, LLC60,655$498.0K0.00%
Bradley Foster & Sargent Inc54,887$450.6K0.01%
Lazard Asset Management LLC45,398$372.0K0.00%
Virtu Financial LLC29,543$243.0K0.01%
Franklin Resources Inc29,101$238.9K0.00%
Alps Advisors Inc27,045$222.0K0.00%
Rockefeller Capital Management L.P.26,773$219.8K0.00%
Militia Capital Partners, LP23,600$193.8K0.09%
Polymer Capital Management (US) LLC23,411$192.2K0.03%
Massachusetts Financial Services Co20,500$168.3K0.00%
Russell Investments Group, Ltd.15,658$128.6K0.00%
Headlands Technologies LLC13,139$107.9K0.01%
Profund Advisors LLC12,921$106.1K0.00%
Mariner, LLC12,904$105.9K0.00%
Prudential Financial Inc10,631$87.3K0.00%
Captrust Financial Advisors10,414$85.5K0.00%
Essential Partners LLC1,833$15.0K0.01%
Nisa Investment Advisors, LLC1,601$13.1K0.00%
Country Trust Bank1,000$8.21K0.00%
UMA Financial Services, Inc.113$9280.00%
Global Retirement Partners, LLC22$1810.00%
Clearstead Advisors, LLC6$500.00%

Sold out (28)

Institutions that held REGENXBIO Inc. at the end of Q1 2025 and filed for Q2 2025 without it.

Not filed for Q2 2025 yet (2)

Institutions that held REGENXBIO Inc. at the end of Q1 2025 and haven't filed a 13F for Q2 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding RGNX in Q1 2025 that haven't filed for Q2 2025
InstitutionShares, Q1 2025Value, Q1 2025
Napatree Capital LLC31,675$226.5K
Lindbrook Capital, LLC153$1.09K